Howard University College of Pharmacy will host a Pharmacy Policy Symposium on March 22nd, 2016 featuring Jonca Bull, MD as the hot topic speaker. Dr. Bull currently serves as the Assistant Commissioner for Minority Health at the Food and Drug Administration. She will discuss the opioid crisis and the FDA's action plan to address it. Dr. Bull has over 20 years of experience working at the FDA as well as in the pharmaceutical industry and clinical practice. She received her medical degree from Duke University School of Medicine.
Howard University College of Pharmacy will host a Pharmacy Policy Symposium on March 22nd, 2016 featuring Jonca Bull, MD as the hot topic speaker. Dr. Bull currently serves as the Assistant Commissioner for Minority Health at the Food and Drug Administration. She will discuss the opioid crisis and the FDA's action plan to address it. Dr. Bull has over 20 years of experience working at the FDA as well as in the pharmaceutical industry and clinical practice. She received her medical degree from Duke University School of Medicine.
Howard University College of Pharmacy will host a Pharmacy Policy Symposium on March 22nd, 2016 featuring Jonca Bull, MD as the hot topic speaker. Dr. Bull currently serves as the Assistant Commissioner for Minority Health at the Food and Drug Administration. She will discuss the opioid crisis and the FDA's action plan to address it. Dr. Bull has over 20 years of experience working at the FDA as well as in the pharmaceutical industry and clinical practice. She received her medical degree from Duke University School of Medicine.
Tuesday, March 22nd, 2016 8 a.m. Armour J. Blackburn Center
HOT TOPIC SPEAKER
TOPIC: THE OPIOID CRISIS AND THE FDA ACTION PLAN
JONCA BULL, MD ASSISTANT COMMISSIONER FOR MINORITY HEALTH, FOOD AND DRUG ADMINISTRATION
Dr. Jonca Bull returned to FDA in August 2012 as the Director of
the Office of Minority Health after most recently serving as Vice President for US Drug Regulatory Policy at Novartis and, prior to that, as Director of Clinical Regulatory Policy at Genentech. Dr. Bull previously served in FDA in a variety of positions in both the Center for Drug Evaluation and Research (CDER) and the Office of the Commissioner spanning 12 years. Dr. Bull also previously spent eleven years providing clinical care in a multi-specialty group practice, and she currently serves as an Assistant Clinical Professor at George Washington University Medical Center. Dr. Bull is a graduate of Princeton University and received her medical degree from Duke University School of Medicine. She did her postgraduate training at George Washington University, is board certified in Ophthalmology, and is a fellow of the American Academy of Ophthalmology.